🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT02826837
Treatments Being Tested
In this study, the investigators assessed the effect of Cetuximab in combin...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2006-09
Trial ID
NCT01564810
Treatments Being Tested
To observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-d...
Status
Unknown
Location
Liaoning Cancer Hospital & Institute
Start Date
2022-08-01
Trial ID
NCT05797883
Treatments Being Tested
To improve the survival in patients with microsatellite stable metastatic c...
Status
Recruiting
Location
Fudan University
Start Date
2024-03-01
Trial ID
NCT06841159
Treatments Being Tested
Try FOLFOX-HAIC combining bevacizumab or cetuximab for initially unresectab...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-05-01
Trial ID
NCT06988852
To confirm the tolerability and safety of combined administration of ONO-79...
Status
Active Not Recruiting
Location
Fujita Health University Hospital
Start Date
2021-09-23
Trial ID
NCT06540261
Treatments Being Tested
This is a clinical research study taking place in Germany. Patients with co...
Status
Recruiting
Location
Charité - Universitaetsmedizin Berlin
Start Date
2025-04-10
Trial ID
NCT06922383
Treatments Being Tested
This is an open label, multicenter, randomized study in Chinese patients wi...
Status
Unknown
Location
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Start Date
2021-09-06
Trial ID
NCT05074966
Treatments Being Tested
This is an open-label, multicenter, randomized study to be conducted in Chi...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2021-09-24
Trial ID
NCT04262635
Treatments Being Tested
PURPOSE: This randomized phase III trial is studying cetuximab and/or bevac...
Status
Completed
Location
Providence Cancer Center at Providence Hospital
Start Date
2005-11
Trial ID
NCT00265850
Treatments Being Tested